Recently, a novelsystem has been described using peptides targeting PD-L1 and PD-1linked to E3 ligase/protein binding components to induce their degradation.This peptide-PROTAC system can effectively lower the PD-L1 and PD-1expression in cervical cancer cells and boost the immune system’sability to fight tumors. The gene discussed is CD274; the disease is cervical cancer.